pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 17·1 min read
save

Epic faces antitrust lawsuits and internal AI strategy turmoil ahead of annual user meeting

Aug 17, 2026·read at STAT ↗RegulatoryNegative

Epic Systems, founded by Judy Faulkner, dominates the U.S. hospital electronic health record market and convenes its annual User Group Meeting with more than 20,000 attendees.

The upcoming gathering arrives as the company confronts a series of unprecedented challenges, notably antitrust lawsuits that question its market dominance.

Internally, Epic is wrestling with tensions over its artificial intelligence strategy and succession planning, raising concerns among staff and customers.

Scrutiny over market control and a recent exodus of employees add further pressure as the firm prepares to unveil its product roadmap.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Epic confronts unprecedented challenges as it prepares to address customers and unveil road map”

read at STAT ↗
515 words · retrieved Aug 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COLILLY

related stories

  • Apr 30STAT+: FDA wants to exclude weight loss drugs from a compounding listSTAT
  • Apr 30STAT+: Five-way obesity drug is super effective — in miceSTAT
  • Apr 30Updated: Early sales of Lilly’s obesity pill appear to trail Novo’sEndpoints
  • Apr 29FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotechBioPharma Dive
  • Apr 29STAT+: A patent win for Pfizer and BridgeBioSTAT